The Procter & Gamble Company (NYSE:PG)
F1Q 2014 Earnings Conference Call
October 25, 2013, 8:30 a.m. ET
Jon Moeller - CFO
John Chevalier - IR
Bill Schmitz – Deutsche Bank Securities
John Faucher – JPMorgan
Dara Mohsenian – Morgan Stanley
Wendy Nicholson – Citigroup
Lauren Lieberman – Barclays
Chris Ferrara - Wells Fargo
Ali Dibadj - Bernstein
Connie Maneaty – BMO Capital Markets
Jason English - Goldman Sachs
Olivia Tong – Bank of America Merrill Lynch
Javier Escalante - Consumer Edge Research
Joe Altobello - Oppenheimer
Bill Chappell - SunTrust Robinson Humphrey
Jon Andersen - William Blair
Mark Astrachan - Stifel Nicolaus
Alice Longley - Buckingham Research
Michael Stieb – Credit Suisse
Caroline Levy - CLSA
Welcome to Procter & Gamble's quarter-end conference call. Today's discussion will include a number of forward-looking statements. If you will refer to P&G's most recent 10-K, 10-Q, and 8-K reports, you will see a discussion of factors that could cause the company's actual results to differ materially from these projections.
As required by Regulation G, P&G needs to make you aware that during the call, the company will make a number of references to non-GAAP and other financial measures. Management believes these measures provide investors valuable information on the underlying growth trends of the business.
Organic refers to reported results excluding the impacts of acquisitions and divestitures and foreign exchange, where applicable. Free cash flow represents operating cash flow less capital expenditures and adjusted for after tax impact of major divestitures. Free cash flow productivity is the ratio of adjusted free cash flow to net earnings.
Any measure described as core refers to the equivalent GAAP measure, adjusted for certain items. P&G has posted on its website, www.pg.com, a full reconciliation of non-GAAP and other financial measures.
Now, I will turn the call over to P&G’s Chief Financial Officer Jon Moeller.
Thanks, and good morning. Before we get to results, I want to start with a few housekeeping items. Consistent with our emphasis on productivity, as well as our focus on annual versus quarterly planning periods, A.G. Lafley and I have decided to apportion our efforts on P&G investor communications as follows.
A.G. will lead our fiscal year end call, providing perspective on the year we’ve just completed and outlining our priorities for the new fiscal year. A.G. will represent P&G at our most significant each year. This year those will be the Barclays Back to School conference and CAGNY. And he will lead the annual shareholders meeting each October.
I’ll head up the non year-end quarterly calls and the remaining investor conferences. We will both continue to meet on a one-on-one basis with current and potential investors. We’ll continue to involve other key executives in investor meetings and conferences, as we have in the past.
Our objective is to provide shareholders the information they want and need in a more productive manner that is consistent with our business planning approach. One last announcement, John Chevalier, who heads up our investor relations practice, will now report directly to me. John was previously reporting to our treasurer, Teri List, who is now at Kraft Foods. John joins me on the call this morning.
Let me move now to our first quarter results. All-in sales grew 2%, including the 2-point headwind from foreign exchange. Organic sales grew 4%, putting us on track to deliver 3% to 4% organic sales growth for the fiscal year. Organic sales growth was driven by strong organic volume growth of 4%. Pricing and mix were both neutral to sales growth for the period.
Organic sales were in line or ahead of a year ago in all reporting segments. Organic sales were up low single digits in developed markets and high single-digits in developing markets. P&G global value market share was around 20% for the most recent 3-month period. We held or grew global market share in businesses representing about two-thirds of global sales.
Moving to the bottom line, all-in earnings per share were $1.04. This includes $0.02 of noncore restructuring costs. Core earnings per share were $1.05, down $0.01 versus the prior year. Foreign exchange was a $0.09 per share headwind. On a currency neutral basis, core earnings per share was up 8% for the quarter.
Core operating profit margin declined 70 basis points as solid organic sales growth and 200 basis points of cost savings were offset by foreign exchange and gross margin mix impacts.
Core gross margin was down 130 basis points. Strong cost savings of 160 basis points and volume leverage was more than offset by geographic and category mix of 140 basis points, foreign exchange of 80 basis points, higher commodity costs, and higher manufacturing startup costs versus the prior year.
Core SG&A costs decreased 60 basis points, driven by overhead cost savings of 40 basis points, marketing spending efficiencies, and volume leverage. These benefits were partially offset by foreign exchange, general wage inflation, and reinvestments in innovation and go-to-market capability.
The effective tax rate for the quarter was 23.8%. The combined impact from tax, interest expense, interest income, non-operating income, and outstanding share count was essentially neutral to core earnings per share growth.
We generated $1.3 billion in free cash flow in the quarter, repurchased $2.5 billion in stock, and returned $1.7 billion of cash to shareholders as dividends. Free cash flow was reduced by a discretionary cash contribution of nearly $1 billion to our German defined benefit pension fund. This is reflected in the change in other operating assets and liabilities line on the cash flow statement.
Free cash flow productivity was 43% for the quarter, including a negative 32 point impact from the pension contribution. This contribution was included in our projection of about 90% free cash flow productivity for the fiscal year.
Overall, we remain on track with each of our fiscal year objectives. We’re focused on four important areas to drive continued improvement in our results. Value creation for consumers and share owners is our top priority.
Operating TSR is our primary business performance measure. Operating TSR is an integrated measure of value creation at the business unit level requiring sales growth, progress on growth and operating margin, and strong cash flow productivity.
Operating TSR drives focus on core businesses, our leading, most profitable categories, and leading, most profitable markets. Our strongest business unit and total company positions are in the U.S. We need to continue to ensure that our home market stays strong and is growing.
We’ll continue to grow and expand our business in developing markets, with a focus on the categories and countries with the largest sizes of prize and the highest likelihood of winning. Developing markets will continue to be a significant growth driver for our company.
We’ll continue to focus the company’s portfolio, allocating resources to businesses where we can create the most value. We will continue to exit businesses where we determine that potential buyers with different capability sets can create more value than ourselves.
Consistent with our focus on operating TSR, we’re continuing to push forward with our productivity and cost savings efforts. We made good progress over the last fiscal year and a half, we have strong plans for fiscal 2014, and are working to accelerate fiscal 2015 plans into 2014.
Versus the target run rate of $1.2 billion, we’re planning more than $1.4 billion of cost of goods savings this fiscal year across materials, logistics, and manufacturing expense. We expect to improve manufacturing productivity by at least 6% this year. We’re up more than 8% fiscal year to date.
We’re continuing the work on North American and European supply chain redesign to lower cost, reduce inventory, and improve customer service. This work will require additional investment in both restructuring and capital, but should generate very attractive returns. We’ll communicate more details as plans are finalized.
We will deliver our 2014 enrollment reduction goals and then work to accelerate [role] reduction’s plan for 2015 into 2014. There are several teams supported by external advisors and benchmarks working in parallel on plans to deliver these reductions. The teams span business sectors, market development organizations, and corporate functions. We’ll be working to consolidate individual team plans into one overall company plan by the end of the calendar year and plan to discuss key elements with you at the CAGNY conference in February.
We continue to drive marketing ROI improvements through an optimized mix of advertising media, greater clarity of messaging, and greater efficiency in non-advertising marketing spending. We expect absolute marketing spending to increase this year, but marketing as a percentage of sales to decline modestly versus the prior year level. We are committed to making productivity a core strength and a sustainable competitive advantage.
We’ll continue to strengthen our innovation efforts. We aim to be the innovation leader in every product category where our brands compete. Near term, we’re shipping major innovation upgrades across the entire baby care line in North America, providing superior dryness, comfort, and fit, particularly overnight, to better deliver what moms want for their babies.
The Ariel pods launch in Western Europe is tracking well above expectations. Consumption trends on Tide pods have accelerated even further in the U.S. behind new trial-building merchandising.
We’re continuing to see strong growth in our new oral care expansion markets, and are experiencing significant growth behind the expansion of our 3D White innovation.
We’re delivering strong market share gains in the U.S. deodorant category, behind the Secret Stress Sweat innovation and on Old Spice, as we launch new scent collections and commercial campaigns.
We’re also strengthening our share position of the U.S. battery business, behind the Quantum innovation and recent distribution increases. P&G battery value share is up nearly 1.5 points for the past three months.
In family care, our recent Bounty upgrades were recognized in external product testing. Bounty had the top three products in the test, including a landslide victory for Bounty Duratowel over all other products.
Recent product packaging and commercial innovations on Pantene are driving strong growth in the Latin America and Central and Eastern Europe, Middle East, and Africa region. Pantene shipments were up double digits in both regions for the quarter.
Next, we’re improving execution and operating discipline. We simply have to execute better, more consistently, and more reliably. It’s not about exhorting the organization to do better, it is about rigorously following tried and true work processes that deliver results. It’s only airing high ROI advertising. It’s disciplined initiative launch qualification and planning. It’s about staying ahead of changing regulatory standards to ensure we’ve maintained a full supply capability. It’s about everyone playing their position and playing it well.
Our progress in operating discipline and execution is beginning to be recognized. In the most recent Advantage Monitor U.S. customer survey, which rates retailer satisfaction with their suppliers, P&G improved its overall ranking for the middle third of the 40 suppliers evaluated to the top third, with significant improvements in areas such as category development and shopper insights. Our goal is to be number one, and our focus is on translating this improved operating performance into better and more consistent top and bottom line results.
Last, we’re making strategic investments in innovation and go-to-market capabilities. The budget increase in R&D will enable us to strengthen our near and mid-term innovation pipeline. Our go-to-market investments are primarily focused on improving sales coverage in our fastest-growing markets and fastest-growing channels.
We believe that the focus we’re bringing to these four areas: operating TSR, productivity, innovation, and operational excellence will enable us to continue to improve results, which brings us to guidance.
We’re reconfirming 2014 guidance, top line, bottom line, and cash. We’re maintaining our organic sales growth range of 3% to 4%. Achieving organic sales growth in the upper half of our target range would result in modest overall market share growth. Foreign exchange is expected to be a sales growth headwind of about 2 points, which leads to all-in sales growth in the range of 1% to 2% for the fiscal year.
On the bottom line, we’re maintaining our forecast for core earnings per share growth of 5% to 7%. This translates to constant currency core earnings per share growth in the range of 11% to 13%.
On an all-in GAAP basis, we expect earnings per share to grow approximately 7% to 9%. This range reflects somewhat lower noncore restructuring costs in fiscal year 2014 versus the prior year.
First half core earnings per share growth will likely be flat to slightly down versus prior year. Second half growth will be much stronger. Our second half forecast is not based on a significant deceleration in organic sales growth.
Second half earnings growth increase is driven by foreign exchange and cost structure. Foreign exchange will be a significant headwind in the first half, but will moderate in the second half at recent spot rates. We estimate that about 70% of the fiscal year FX impact will be in the first half of the fiscal year.
We’ll also annualize operating impacts from last year’s Venezuelan bolivar devaluation in the second half. There are several second half cost benefits. Manufacturing startup costs will largely annualize in the second half of fiscal 2014 and productivity savings will build throughout the year.
As you prepare your sales and earnings estimates for Q2, there are a few items you should keep in mind. Recall that the second quarter base period includes a $0.07 per share one-time gain from the sale of the Western European bleach business. We expect the foreign exchange headwind for Q2 to be similar to the impact we saw in the first quarter.
We’re expecting a heightened level of competitive promotional spending, ahead of our product initiative’s launch in early next calendar year, especially in North American fabric care and beauty.
We expect to deliver another strong year of about 90% free cash flow productivity. Our plans assume capital spending in the range of 4% to 5% of sales and share repurchase in the range of $5 billion to $7 billion, continuing to deliver on our commitment of cash return to shareholders.
In addition to the assumptions included in our guidance, we continue to be very transparent about some key items that are not included. Foreign exchange continues to be very volatile. Rates improved somewhat in September and October, largely reversing the large negative move we saw in late July and August. But this could quickly change.
The guidance we are reconfirming today is based on mid-October spot rates. We’re closely watching the unrest in Egypt, which is a large business for us, and a base of export for the balance of Africa. Venezuelan price controls, access to dollars for imported products, and devaluation present risks, as do import restrictions and price controls in Argentina. Finally, our guidance assumes no further degradation in market growth rates.
We continue to operate in a volatile environment, with uncertainty in the foreign exchange, decelerating market growth rates, and a rapidly developing policy environment. Against this backdrop, we have good market share momentum, a number of strong innovations coming to market over the balance of the year, and savings from productivity improvements that will continue to build.
Our first quarter results were in line with what we expected, putting us on track to deliver our goals for the fiscal year and enabling us to make progress toward our long term growth objectives. We’re making targeted investments in our core business in the most promising developing markets and biggest innovation opportunities, and are aggressively driving the productivity and cost savings.
Above all, we remain focused on value creation for consumers and for our share owners. That concludes our prepared remarks. As a reminder, business segment information is provided in our press release and will be available in the slides, which we’ve posted on our website, www.pg.com, following the call.
I’d be happy now to take any questions.
[Operator instructions.] Your first question comes from the line of Bill Schmitz with Deutsche Bank. You may begin.
Bill Schmitz - Deutsche Bank
Two quick ones. China, it seems like business is doing pretty well market share-wise, everywhere in the world except for China. But if you look across categories, at least in the Nielsen data we have, you know, laundry, diapers, toothpaste, it seems like shares are under quite a bit of pressure recently. So wondering kind of what’s going on there and sort of what the plan is to kind of fix that.
And the second thing is, and maybe I’m making a huge deal about this, but this [influx] technology on the package side, could that be a game-changer going forward in terms of how you make and buy bottles and give you a pretty neat competitive cost structure advantage?
First of all, China, volume market share was essentially flat in the quarter. We did lose a little bit of ground on value share, though that continued to build sequentially, has continued to build over the past 12, 6, 3 months. So we’re reasonably comfortable about our position there. We’ve got a very strong innovation program coming in the back half of the year and expect China to continue to be a significant source of growth for us.
On [influx], this is something we actually talked about at CAGNY. It’s a disruptive proprietary breakthrough in the packaging area, and when rolled out across our businesses, it should deliver about $150 million in cost savings per year and will allow us to avoid about $50 million in capital expenditures annually. It will also bring significant sustainability benefits. It could reduce resin usage by over 100 million pounds per year and eliminate energy usage by over 250 million kilowatt hours.
And finally, we’re hopeful that this breakthrough will allow us to reduce our time to market for package development by up to 50%. So it is something that we’re excited about and should benefit from.
Your next question will come from the line of John Faucher with JPMorgan.
John Faucher - JPMorgan
Wanted to talk a little bit about the negative FX leverage you’re seeing here in terms of from the top line to the bottom line, particularly how your manufacturing footprint is impacting that, whether that’s a big transactional hit as you’re importing products into countries like Brazil.
And then to sort tie that in, I’ll try to make this two questions, it’s actually one question, can you talk a little bit about the plan for local manufacturing? You’ve got a lot of startup costs there. When can that go to being a real benefit as you look at not just your manufacturing cost, but also the ability to be more flexible when you’re manufacturing locally?
You’re absolutely right on the dynamic on foreign exchange and the divergence between the top and bottom line impact. That disparity is primarily driven by very large currency moves in countries that have a significant dollar and euro denominated cost structure for imported materials and finished product.
Just for perspective, Japan and Venezuela, which both fall into that category, account for more than 40% of the FX-related profit hurt on the quarter. And you’re also right that as we’re able to localize more of the manufacturing, not only will we save a significant amount of money, but we’ll in essence be operationally hedged more on the bottom line.
Timeline, we’re bringing on a number of new facilities currently, as reflected in the startup cost figures that we’ve been discussing for the past couple of quarters. I would look at that to yield benefits more in our next fiscal year.
Your next question comes from the line of Dara Mohsenian from Morgan Stanley.
Dara Mohsenian - Morgan Stanley
First, just a detail question. Can you tell us how much U.S. organic sales growth was in the quarter in emerging markets? And then the real question is, I just was hoping you could characterize the pricing environment you’re seeing right now, both in the U.S. and around the world. Clearly you’ve made significant market share progress, but you did highlight you expected heightened competitive activity going forward. So should we expect pricing to deteriorate a bit going forward in the balance of the year? And do you view heightened competitive activity as a big threat, at this point, to your markets progress?
First, on U.S. growth rate, organic sales was about 2%, and that’s also consistent with the total developed markets growth rate, which was low singles. Developed markets grew about 8%.
On pricing, let me say a couple of things. First, relative to history, including the last quarter, if you look at price, inclusive of promotion, it was neutral to organic sales growth on the quarter. If you look further back, price, inclusive of promotion, has been neutral to positive for 11 consecutive quarters. It’s been neutral to positive for 9 consecutive years.
We would much rather invest a dollar in innovation or equity, because those benefits are proprietary and sustainable. Promotion, price discounting, there’s nothing proprietary about it, and it’s typically not sustainable. If you look at our promotion, the percentage of sales that moved on promotion in the July-September quarter, it was down versus a year ago, not up. So that’s the past.
As we look forward, it’s important that while we’d rather spend money on innovation and equity, it’s important we be competitive from a promotion standpoint. We are not going to be ones who lead promotion escalation, but we will be competitive.
We do have a period coming up in the next quarter here that precedes pretty significant initiative launches for us, and it’s not atypical in that environment that we see a little bit of an increase in promotion from the competitive set trying to load consumers ahead of our initiatives.
So we do expect that environment to tighten over the next three months as we head into our big initiative launch. Again, that’s not something that we’ll be leading. We’ll continue to focus on innovation and equity.
Your next question comes from the line of Wendy Nicholson from Citigroup.
Wendy Nicholson – Citigroup
On the gross margin, I know you don’t want to give too much specifics in terms of the full year outlook, but I assume some of the manufacturing startup costs are going to fall away. Hopefully, anyway. Can you comment kind of over the full course of this year whether you expect gross margin to be up or down?
It certainly will sequentially improve, and should be positive certainly by the fourth quarter, early fourth quarter. We’ll have to see where it nets out total year. I honestly don’t think that much about that. But we do expect for gross margin progress to turn positive by the end of the year.
Your next question comes from the line of Lauren Lieberman with Barclays.
Lauren Lieberman – Barclays
I wanted to ask a bit about beauty margins. They were up so significantly in the quarter I was curious what was driving that. The change in allocation of resources, or holding back as you sort of sort out plans for skincare? So questions on that.
And then coupled with that was in your prepared remarks, Jon, when you mentioned the heightened promotional environment expected in the second quarter ahead of initiative launches, you actually mentioned not just fabric care but also I think you said beauty, and that was sort of news to me if there’s something significant coming in beauty, so if you could talk about that, it would be great.
A large part of the quarter to quarter variability in profitability in beauty is being driven by initiative timing, and we have, as I mentioned in the prepared remarks, and as you referenced, we have a strong slate of initiatives coming to market December through March in beauty. The specifics are not items that we’ve disclosed yet, and we’ll do that as we get closer to the events themselves, but there is significant innovation coming.
The other thing that’s impacting quarterly variability, which is a great thing, is real progress on productivity within the beauty business. They’re working that as hard as anybody, and are frankly doing a great job.
Your next question comes from the line of Chris Ferrara from Wells Fargo.
Chris Ferrara - Wells Fargo
I just wanted to ask about Tide Simply. So I guess relative to Charmin and Bounty basic, it looks like the price gap there between the premium and the mid-tier segment in those respective categories is not as wide as in direct to laundry. Premium Tide versus the baseline is a very, very large gap. So the gap between Tide Simply and premium Tide is likely to be wider than what it is between Bounty and Charmin basics, and those mainline products.
So I guess the question is can you use those two as a benchmark? And how do you manage that? And is the thought process even correct there?
It ultimately comes down to strong consumer segmentation and benefit alignment against those segments and the benefits that they’re seeking. And it’s more about that than it is about relative price point.
And as you can imagine, we’ve been working this for some period of time, as you know, and we’ve been working very hard to ensure that the offering is very attractive to the consumer segment that we’re targeting and is less attractive to the current Tide consumer, which we believe we have achieved.
And that is more the mark of success on things like Bounty Basic, Charmin Basic, Luvs versus Pampers, that consumer segment and benefit alignment with their needs that drives success.
Your next question comes from the line of Ali Dibadj from Bernstein.
Ali Dibadj - Bernstein
Two things. I first wanted to follow up on the language in the press release and your prepared remarks about the $0.07 I guess now one-time gain you asked us to include in your core last year, although it felt like it was smaller than $0.07 last year. I’m just a little confused. Are you now asking us to restate that and take out the $0.07? Or what do you want us to do with that?
And then the other question I had is about the 200 basis points that you’re saving this quarter. Obviously that’s good. Is that enough relative to the way your competitors are doing? It certainly sounds like you’re going to be ramping up that savings number. How much higher do you think it ramps to and for how long?
First, relative to the $0.07 gain, what we’re asking you to do is just simply be aware of it. We’re just providing that as an awareness point. What you do with that is obviously your call. But we like people to not be surprised, and that’s simply why we’re calling it out. It will be in our core numbers in the base, and will be reported as part of our core comparison. So we’re not restating anything here.
On savings, look, there’s no amount of savings that’s enough. Now, there is an amount of savings that’s too much, when it starts cutting into capabilities for growth and those kinds of things. But we’re going for everything we think is feasible and then asking ourselves is there more after that?
And I’m not going to speculate on the ultimate amount of savings, but I think as you’ve seen both last year and this year, generally we’re exceeding, as opposed to underdelivering, our savings targets.
Last year we had $1.2 billion in cost of goods savings. That’s about what we need to deliver the $10 billion objective this year. So far we’re at about $1.4 billion. Last year we significantly overdelivered the SG&A enrollment, and this year we’re committed to deliver our 2014 target and work to accelerate 2015 into 2014.
And we really want to make this, as many of us have described before, an ongoing part of our business model, our culture, our ethos. And I think there’s a lot of possibility, to the extent that we’re able to accomplish that.
Your next question will come from the line of Connie Maneaty from BMO Capital Markets.
Connie Maneaty - BMO Capital Markets
I remember when A.G. first came back he was talking about the cost structure in some parts of the developed world still being too high. I’m wondering where you stand on what sounded like it would be another more traditional type of bricks and mortar restructuring program that would run concurrently with the productivity initiative underway.
That’s what I was referring to in my prepared remarks relative to supply chain redesign in both North America and Western Europe, which is underway. It’s in process, and we’ll talk about it more as we kind of finalize our plans.
But that is a significant opportunity to both reduce cost, improve cash through reduced inventory, and importantly, improve customer service, and we’re pretty excited about that that opportunity. Basically, our supply chains in both of those markets have come about over years, and through a number of acquisitions.
And this is an opportunity to step back and say, you know, if we were doing this over, how would we do this? What are the right levels of aggregation in terms of number of categories that are produced at a site? What are the right locations? How do you think about distribution opportunities serving existing customers and new customers? And so pretty excited about that opportunity, and we will bring more information to you as we finalize those plans.
Your next question will come from the line of Jason English from Goldman Sachs.
Jason English - Goldman Sachs
I wanted to come back to beauty. You talked a little bit about the innovation slate coming up and some of the margin expansion. I wanted to drill down on the organic sales growth. You were showing signs of acceleration to year-end. We see deceleration despite the easy comp, and it also stands in contrast to what looks to be, in terms of U.S. consumption offtake, accelerating trends. Can you help us understand what drove that deceleration, whether there’s anything transitory behind it, and maybe what’s working and what isn’t within that segment?
First of all, this is a very competitive category. It’s a category where I will readily admit we continue to have more work to do. So we’re not yet where we want to be on this business. There are pieces of it that are working very well. Our personal cleansing business was up high single-digits on the quarter, our cosmetics business is doing extremely well, our deodorants business is doing extremely well.
I mentioned Pantene. In several parts of the world it’s doing well. We continue to need to make progress on North American Pantene, on Olay, and we need to make progress in our salon professional businesses. So those are kind of the strengths and the weaknesses, as it were, and we’re fully focused on maximizing the opportunity behind the strengths and addressing the opportunities.
Your next question will come from the line of Olivia Tong from Bank of America Merrill Lynch
Olivia Tong – Bank of America Merrill Lynch
Want to talk a little bit about the share improvement. Obviously it continues. Where do you think that can top out at?
Well, as I said several times on this call, we are in a very competitive market. Our expectation is that when we get everything working, we should be able to build a little bit of share each year. We’re never going to be in a position where 100% of our business is building share at any given point in time. That’s just not a realistic scenario in a very competitive industry that we compete in.
We’ve talked about targeting kind of two-thirds to 70% of the business growing share, holding or growing share, at any point in time, and that’s the level that leads to modest share growth on an annual basis. So that’s what we’re targeting.
Your next question will come from the line of Javier Escalante from Consumer Edge Research.
Javier Escalante - Consumer Edge Research
Question on the gross profit, or gross margin side. To what extent does a lot of what is happening have to do with the category mix in which basically the fabric and baby care are the two [unintelligible] that are leading the growth? And in that context, knowing that beauty and grooming are challenged, can you help us understand healthcare, why the deceleration beyond the recall of the pet food product?
You’re absolutely right, in terms of the drivers of part of the gross margin pressure. There’s about 140 basis points of mix impact within that gross margin comparison. Approaching half of that is the product mix, exactly what you referenced, which is faster growth in lower gross margin businesses like fabric care and our paper businesses and slower growth in some of our higher gross margin businesses.
In terms of healthcare, the real impact on the quarter was the recall on pet. The good news there is we’re back up manufacturing full speed a perfectly great product. And so that should be in the past.
Your next question will come from the line of Joe Altobello with Oppenheimer.
Joe Altobello - Oppenheimer
Just in terms of the portfolio, I think one of the things that A.G. has tried to hammer home the last three or four months has been that Procter needs to be more focused, and I think the word he’s used a number of times is “choiceful.”
And so on that point, can you give us an example or examples of businesses where you believe you’re underinvesting right now, and where you’re overinvesting? And also, could you see yourself doing something like Unilever has done in the past, or like Kimberly-Clark has done more recently, where you actually pull out of certain geographies or categories in whole?
And then also in terms of a housekeeping item, you mentioned that you held or gained share in two-thirds of your businesses. I think that was a global number. What was that number in the U.S.?
The two word choices that you provided are accurate, focused and choiceful. And that’s what we’re all working to do here. Obviously you can appreciate from a competitive standpoint why I wouldn’t want to lay over many cards right here in terms of where we’ll accelerate investment or decelerate investment.
But it is very much, as I said in our prepared remarks, a focus of ours, which is flowing investment to the areas, both businesses and geographies, where we believe we can create disproportionate value, and looking real hard at businesses where we’re struggling to create value and looking to see if somebody else could potentially create more value than us.
We have pulled out of regions in the past. We used to be in Asia, in the tissue/towel business. We used to be in Western Europe in the tissue/towel business. And we’re now largely a North American tissue/towel business. And that was all driven by our assessment of our ability to create value in that industry, which we viewed as low potential.
So these are things, both categories and geographies, that we’ll continue to look at. And as we always have done, whether it’s pharmaceuticals or Folgers or snacks, or the Western European tissue/towel business, where we determine that we can create more value on any business in a divestment context, there are two pieces of that. One is what our prognosis is going forward, the other is obviously we’re not going to exit businesses in a value dilutive manner, so we need to have somebody who’s willing to monetize some of that value they can create for our shareholders.
Your next question will come from the line of Bill Chappell from SunTrust.
Bill Chappell - SunTrust Robinson Humphrey
Jon, you had talked I guess this morning on CNBC about Europe and kind of moving sideways. And I was just wondering if maybe you can give us a little more color there, because as you alluded to, a lot of other companies are seeing pockets of growth in certain areas, and didn’t know if it really is just straight sideways, or if there’s any sign of hope, or kind of just any color you have would be great.
There are definitely areas that are stronger within Europe. I’m not telling you anything you don’t know. Northern Europe is certainly stronger than Southern Europe. Southern Europe continues to be a real struggle. And there are markets that are pockets of hope, if you will.
But I want to step back on the whole Western European thing for a second. Changes in Western Europe in the consumer products category space have never been dramatic, and they continue to not be overly dramatic. You know, growth tends to oscillate between minus 1 and plus 1, and it’s a good year when it’s plus 1 and a bad year when it’s minus 1. And we’re not seeing significant departures from that aggregate picture.
And so it continues to be an environment where we think we can build sales. We believe we can build profit and create value. It’s an area that we’re focused on. But we just don’t see a rebound to date.
Your next question will come from the line of Jon Andersen from William Blair.
Jon Andersen - William Blair
I’m interested in asking about new channels, specifically the online channel. How important is the online channel to you today? What role does it play going forward? And are there distinct advantages to Procter from selling online? And I’m thinking of things like increased consumption, reaching more consumers, or perhaps it’s more profitable to sell through that channel.
Well, we want our products to be available wherever, whenever, and however consumers want to shop. And there is certainly a segment of consumers in some categories that want to shop online, and we’ll work to be available for them. The amount of our business that’s currently in that channel varies by category. Still, as you would expect, the vast majority of our products are sold in traditional channels.
And I think the channel offers several advantages, and several disadvantages, just as our other channels do. It’s a very effective way to target consumers, both from a marketing standpoint and then conversion to purchase. So we’ll continue to look at it from that standpoint. But we really want to be present and viewed as best in class in each of the retail channels.
Your next question will come from the line of Mark Astrachan from Stifel.
Mark Astrachan - Stifel Nicolaus
Do you think the competitive environment is getting better or worse relative to your expectations? And I say this in the context of some of what I thought relatively provocative comments by your large competitor yesterday that it plans to rebase cost to fund investments. And sort of related to that, how do you think about the spending between promotional allowances and real advertising spend? I know you had mentioned that as a percentage of sales it would be up but less so absolutely as a percent?
That’s true of our aggregate marketing expense. Promotion expense in the July-September quarter, in terms of the percentage of our sales that moved on promotion, was actually down 7% versus a year ago. If you look at the total industry, it was about flat versus a year ago. So there are certain categories, certain items, certain competitors, where there may be an escalation in promotion, but it’s not a broad characteristic of the environment, at least as we’ve seen it to date.
Your next question will come from the line of Alice Longley from Buckingham Research.
Alice Longley - Buckingham Research
A housekeeping question and then something else. Can you update us as to your category growth rates in emerging regions and the U.S.? And then could you break out the 2% organic sales growth that you had in the U.S. in terms of volume mix and price? And then my other question is the 140 basis point negative hit to gross margins from mix, are you expecting that to lessen as you go through the year? And maybe [by half]? Is that a significant part of the gross margin improvement you’re expecting?
In terms of market growth rates, broad strokes we see 1% growth in developed markets, about 7% in developing markets, and aggregate, developing markets ranged from kind of mid-single digits to low double-digits, depending on the region. And the developed markets range anywhere from 2% market value growth in North America to about a 1% decline, consistent with what I was saying earlier, in Western Europe.
Relative to the 140 basis points mix impact and how that evolves going forward, as I mentioned in my response to Javier, about half of that is geographic and about half is product. And I would hope that over time, as we get our beauty business growing at market growth rates, the product portion of that would largely dissipate.
I do expect we’ll continue to have disproportionate growth in developing markets, and we’re not yet to the point in terms of economic development where those margins will be equal to the balance of the rest of the world. So we will continue to see some drag on mix from a geographic standpoint.
Your next question is from the line of Michael Stieb from Credit Suisse.
Michael Stieb – Credit Suisse
I was wondering if you could give us some more detail on the volume decline in the grooming segment. Is that largely due to category weakness? Or is it from some share losses?
The category in the last three months was about flat. I think it was a 99 index. We did lose a little bit of share in the latest quarter. That was primarily driven by disproportionate growth in the disposables section of the business, where we are less well-developed. The encouraging piece of it is that Fusion continued to grow share, and that’s a good thing long term. And if you look over longer periods of time, last year for example we built share in blades and razors, and I would expect that would be more characteristic of the situation going forward.
Your final question comes from the line of Caroline Levy from CLSA.
Caroline Levy - CLSA
Jon, if you could just go back to the North America share question, I don’t think we got an answer. Just if you could give directionally where things were strongest and weakest. And specifically in cleaning materials, so Tide Pods, if you could just break out what happened on the pod side versus the liquid laundry side.
Thanks for giving me a chance to recover there. Multipart questions, my feeble memory sometimes gets the best of me. In North America we’re holding or growing share in businesses representing between two-thirds to 70% of sales. So that continues to hold up very nicely. I actually don’t have segment level in terms of pods versus liquids versus powder shares in front of me here, but please feel free to call John or Katie or Brian during the balance of the day and they can get you that information.
We have no other questions at this time.
Thank you, everybody, for joining us this morning. As I mentioned earlier, we’re reasonably happy with our first quarter results. In terms of its relation to our expectation, we know we still have more work to do. We’re determined to do that, and we look forward to connecting with each of you soon. Thanks a lot.
Copyright policy: All transcripts on this site are the copyright of Seeking Alpha. However, we view them as an important resource for bloggers and journalists, and are excited to contribute to the democratization of financial information on the Internet. (Until now investors have had to pay thousands of dollars in subscription fees for transcripts.) So our reproduction policy is as follows: You may quote up to 400 words of any transcript on the condition that you attribute the transcript to Seeking Alpha and either link to the original transcript or to www.SeekingAlpha.com. All other use is prohibited.
THE INFORMATION CONTAINED HERE IS A TEXTUAL REPRESENTATION OF THE APPLICABLE COMPANY'S CONFERENCE CALL, CONFERENCE PRESENTATION OR OTHER AUDIO PRESENTATION, AND WHILE EFFORTS ARE MADE TO PROVIDE AN ACCURATE TRANSCRIPTION, THERE MAY BE MATERIAL ERRORS, OMISSIONS, OR INACCURACIES IN THE REPORTING OF THE SUBSTANCE OF THE AUDIO PRESENTATIONS. IN NO WAY DOES SEEKING ALPHA ASSUME ANY RESPONSIBILITY FOR ANY INVESTMENT OR OTHER DECISIONS MADE BASED UPON THE INFORMATION PROVIDED ON THIS WEB SITE OR IN ANY TRANSCRIPT. USERS ARE ADVISED TO REVIEW THE APPLICABLE COMPANY'S AUDIO PRESENTATION ITSELF AND THE APPLICABLE COMPANY'S SEC FILINGS BEFORE MAKING ANY INVESTMENT OR OTHER DECISIONS.
If you have any additional questions about our online transcripts, please contact us at: firstname.lastname@example.org. Thank you!